P1–357: Biomarker strategy for enrichment and monitoring of biological effect in ACCTION, a phase II study of ACC‐001 (vanutide cridificar) for Alzheimer's disease. (1st July 2013) - Margolin, Richard; Ketter, Nzeera; Guthrie, Spencer; Deegan, Denise; Baher, Linda; Tschopp, Renee; Marek, Kenneth; Seibyl, John; Novak, Gerald; Streffer, Johannes; Pachai, Chahin; Wyman, Bradley; et al.